DigestRedComo funciona
Red
/
Empresas
Ed
No verificado

Edgewise Therapeutics

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaMedicina - VariosSalud

13 Comunicados de prensa

Ver todos los comunicados de prensa
11/03/2025
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
04/03/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Cardiología
Eventos
Web y redes sociales
Edgewise Therapeutics to Present at the Leerink Partners Global Healthcare Conference on March 11, 2025
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
22/01/2025
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
13/01/2025
Web y redes sociales
Eventos
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
07/01/2025
Eventos
Web y redes sociales
Biotecnología
Sanidad
Farmacéutica
Salud
Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
16/12/2024
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Industria
Eventos
Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
05/12/2024
Ciencia
Higiene alimentaria
Medicina - Varios
Cardiología
Biotecnología
Sanidad
Farmacéutica
Salud
Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
26/11/2024
Biotecnología
Farmacéutica
Salud
Eventos
Web y redes sociales
Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
07/11/2024
Mercado de valores
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0
01/10/2024
Eventos
Ferias y Congresos
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Fuente
Edgewise Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0